About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT02501239

Health At Every Size and Acceptance and Commitment Therapy vs. Behavioral Weight Loss for Obesity and Depression in Women

The primary aim of this project is to conduct a randomized controlled pilot study evaluating the feasibility and potential effectiveness of a newly developed combined Health At Every Size and Acceptan...

Lead sponsor: Dartmouth-Hitchcock Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Dartmouth-Hitchcock Medical Center

Collaborators

Hitchcock Foundation

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•English-speaking
•Major Depressive Disorder (assessed using the Structured Clinical Interview for DSM-IV, SCID-IV)
•Body Mass Index (BMI) greater than or equal to 30
•Not taking medications or on stable medication regimens (i.e. no medication changes for six weeks prior to enrollment or during the study)

Exclusion Criteria

•current substance dependence
•history of psychotic symptoms
•high risk of suicide/self-harm
•current enrollment in a weight-loss program
•weight loss surgery in the past year
•current psychotherapy
•inability to postpone weight loss or depression treatment interventions for the duration of the study
•taking antipsychotic, tricyclic, or oral corticosteroid medication
•unwilling to be randomized to the study treatments

Related studies

RECRUITINGPhase 2

Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder

NCT05837104 · Bipolar I Disorder, Depression, Anxiety, and more

Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss

NCT06894498 · Obesity and Obesity-related Medical Conditions, Weight Loss

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more

RECRUITINGPhase 3

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

NCT06937086 · Ulcerative Colitis, Obesity or Overweight

RECRUITINGPhase 4

Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression

NCT06833788 · Postpartum Depression (PPD)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 26, 2018Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment19

Start dateAug 2015

Last updatedApr 26, 2018

Condition

Depression Obesity

Locations shown

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 26, 2018Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions